Investigating the role of microRNA210 in brain inflammation after ischemic stroke
MicroRNA210 and neuroinflammation in acute brain injury of ischemic Stroke
This study is looking at how a tiny molecule called microRNA210 affects inflammation in the brain after a stroke, with the goal of finding new ways to help stroke patients recover better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Loma Linda University NIH-funded |
| Lab location | 1 site (Loma Linda, UNITED STATES) |
| Project ID | NIH-10579511 on NIH RePORTER |
What this research studies
This research focuses on understanding how microRNA210 influences neuroinflammation in the context of acute ischemic stroke. The study aims to explore the molecular mechanisms behind brain injury and inflammation, particularly how microglial cells respond to ischemic conditions. By examining the effects of inhibiting microRNA210, researchers hope to identify new therapeutic targets that could lead to more effective treatments for stroke patients. The approach includes both laboratory experiments and analysis of inflammatory responses in brain cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced an ischemic stroke and are facing challenges related to brain injury and inflammation.
Not a fit: Patients who have not experienced an ischemic stroke or have other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that reduce brain inflammation and improve recovery outcomes for stroke patients.
How similar studies have performed: Previous research has shown promising results in targeting neuroinflammation for stroke treatment, suggesting that this approach could be beneficial.
Where this research is happening
Loma Linda, UNITED STATES
- Loma Linda University — Loma Linda, United States (Active)
Researchers
- Principal investigator: Ma, Qingyi — Loma Linda University
- Study coordinator: Ma, Qingyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.